NCT01267955 2026-03-18Vismodegib in Treating Patients With Advanced ChondrosarcomasNational Cancer Institute (NCI)Phase 2 Active not recruiting45 enrolled 10 charts
NCT01878617 2025-11-13A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed MedulloblastomaSt. Jude Children's Research HospitalPhase 2 Active not recruiting660 enrolled
NCT06357988 2025-10-20Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T)National Cancer Institute (NCI)Phase 2 Active not recruiting35 enrolled